## Colombia Wins Andean Court Ruling Upholding Compulsory License for ViiV Healthcare HIV Drug
Colombia has secured a landmark ruling from the Court of Justice of the Andean Community, with the tribunal upholding the legality of a compulsory license issued two years ago for an HIV medicine sold by ViiV Healthcare. The decision signals a major validation of public-health-driven IP policy within the Andean bloc, establishing a precedent that other member states may invoke when confronting access-to-medicine pressures.

The regional tribunal, which resolves trade and intellectual property disputes among Bolivia, Colombia, Ecuador, and Peru, found that Colombian authorities properly justified invoking the compulsory license and correctly set an expiration date for its use. The ruling rejected claims that the government had breached Andean regulations, affirming that such measures are permissible when grounded in public-interest justifications. ViiV Healthcare, the pharmaceutical company behind the drug, did not immediately respond to requests for comment on the decision.

The outcome reinforces Colombia's legal footing to pursue similar compulsory licensing strategies for essential medicines in the future, a tool that allows governments to authorize generic production or importation of patented drugs during public health emergencies. Health officials in Bogotá have framed the approach as critical for expanding access to life-saving treatments amid pricing disputes with multinational drugmakers. The ruling also underscores the growing willingness of national governments across Latin America to challenge pharmaceutical patent monopolies through multilateral legal channels.
---
- **Source**: STAT News
- **Sector**: The Vault
- **Tags**: compulsory license, ViiV Healthcare, HIV medicine, Andean Community Court, intellectual property
- **Credibility**: unverified
- **Published**: 2026-05-11 20:48:23
- **ID**: 81947
- **URL**: https://whisperx.ai/en/intel/81947